EADO - European Association of Dermato-Oncology

Startseite
Schweiz
Zürich
EADO - European Association of Dermato-Oncology

The EADO is a non-profit association dedicated to promote, coordinate and improve clinical and labor

03/02/2026

Scientific Advancements and Clinical Tools: Insights from Rome
During the EADO Brainstorming Meeting in Rome, the EADO Board advanced several key initiatives aimed at Improving skin cancer management across Europe. Prof. Dr. Lidija Kandolf (Belgrade, Serbia) provides an update on the latest clinical guidelines and digital resources now available to the dermatological community.

Key Updates:
• New Guidelines: The EADO Board has nearly finalized the clinical guidelines for Cutaneous Squamous Cell Carcinoma and initiated a dedicated project for Rare Cancers.

• EADO Website Tools: To support daily clinical practice, particularly for early-career researchers and clinicians, the EADO website offers the EADO Navigator, risk calculators, nomograms, and staging tools for various skin cancers.

Upcoming: 22nd EADO Congress in Prague
We invite you to join the global dermato-oncology community at the 22nd EADO Congress, taking place in Prague from April 23–25, 2026.

👉LINK IN BIO.

16/01/2026

⏰ Good news for researchers and clinicians!
The abstract submission deadline for the 22nd EADO Congress has been officially postponed. You now have extra time to prepare and submit your work.

📅 New deadline: 29 January 2026

This is a valuable opportunity to:
• Present your research at a well-established international meeting
• Share your data with the global dermato-oncology community
• Contribute to high-level scientific discussion in Prague (23–25 April 2026)

If you were close to submitting — or needed a bit more time — now is the moment.

👉 Submit your abstract via the link in bio
We look forward to receiving your contributions and welcoming you to EADO 2026.

24/12/2025

🎄 Season’s Greetings from EADO 2026 🎄
We would like to wish our global dermato-oncology community a joyful Christmas and a peaceful start to the New Year.

The 22nd EADO Congress, taking place in Prague from 23–25 April 2026, is steadily approaching and will once again serve as a key international platform for education, scientific exchange, and collaboration in melanoma and skin cancer.

With a comprehensive scientific program and leading experts from around the world, EADO 2026 aims to foster meaningful dialogue and advance clinical practice and research.

✨ Important reminder before the holidays:
📌 Abstract submission deadline: 15 January 2026
📌 Early Bird registration deadline: 15 January 2026

Submitting your abstract is a great opportunity to showcase your work, while early registration allows you to secure your place at a reduced fee.

🎁 We look forward to welcoming you to Prague in the spring.
Until then, thank you for being part of the EADO community—and enjoy a warm and restful festive season.

19/12/2025

Join the Global Leaders in Dermato-Oncology! 🌍✨
Why should you join EADO? Prof. Dr. Josep Malvehy, President of the European Association of Dermato-Oncology, shares the many reasons why this is the essential “umbrella” for skin cancer professionals worldwid:

“… you will find a lot of networking, a lot of education programs, a lot of science to share. EADO is expanding every year and covers all the fields of skin cancer—from prevention and detection to education and research...”

📍 Save the Date: EADO 2026 Meeting in Prague!
The 22nd EADO Congress is heading to the beautiful city of Prague! Join over 1,000 participants for the world’s leading meeting in dermato-oncology.

• When: 23–25 April 2026
• Where: O₂ universum, Prague, Czech Republic
• Website: eado2026.com

⚠️ ACT FAST! Early Bird tickets are available for a very limited time. Secure the best rate before the deadline on 15 January 2026.

Don’t miss out on:
✅ Cutting-edge science and research
✅ Global networking opportunities
✅ Specialized task forces on biomarkers and new therapies

🔗 Register now & join the community: Link in Bio!

12/12/2025

Prof. Dr. Giovanni Pellacani (), President of SIDeMaST ( - the Italian Society of Dermatology and Sexually Transmitted Diseases) Full Professor of Dermatology at Sapienza University of Rome (), as well as Director of the Dermatology Unit at Policlinico Umberto I .umberto1 — shares his wisdom with the next generation of dermato-oncologists. 👨‍⚕️📚

He encourages young clinicians to do what they love, innovate boldly, and always keep the patient at the heart of their work.

20/11/2025

Prof. Dr. Jeffrey Gershenwald (, Houston) highlighted ongoing international efforts to update and refine the Melanoma Staging System.

During a session co-chaired with Prof. David Elder (University of Pennsylvania), key topics included:

– The debate around melanoma overdiagnosis and its implications for clinical practice
– Advances in AI-driven melanoma classification, presented by Dr. Allan Halpern
– The need to build a revitalized global melanoma database to inform future revisions of the AJCC staging system

📢 Prof. Gershenwald invites centers worldwide — especially across Europe — to contribute high-quality melanoma datasets to help shape the next generation of evidence-based staging.

📍Stay tuned for updates, and join us in Prague for EADO 2026 to learn more.

12/11/2025

In Part 2 of his conversation, Prof. Dr. Josep Malvehy, President of the EADO and Director at Hospital Clínic Barcelona, expands on how AI and natural language tools are reshaping the future of dermato-oncology.

🧠 From analyzing vast datasets in minutes to creating AI-generated control groups for clinical studies, these technologies are revolutionizing both research design and daily decision-making.

📊 As Prof. Malvehy reminds us — whether you’re a young doctor or an experienced clinician — understanding and integrating AI tools will soon be essential for advancing precision care in dermatology and oncology.

📍Stay tuned for more insights on how innovation meets clinical practice.

👉See you at the 22nd EADO Meeting 2026 in Prague. LINK IN BIO 🔗

07/11/2025

In this conversation, Prof. Dr. Josep Malvehy, President of the EADO and Director at Hospital Clínic Barcelona, shares his perspective on how AI technologies are reshaping dermatology and skin cancer care.

🧠 “AI doesn’t replace your knowledge — it complements it.”
From 2D and 3D total body imaging to advanced analytics and natural language tools, AI is becoming a valuable ally for clinicians, supporting diagnostics, research, and patient management.

💡 As Prof. Malvehy highlights, understanding how to interpret and apply AI-generated insights is key: knowing when it helps — and when it doesn’t — will define the next generation of clinical excellence.

📍Follow for Part 2 to explore how AI and real-world data are shaping the future of dermato-oncology.

06/10/2025

At , Prof. Dr. Swen Malte John (University of Osnabrück, Chair of the EADV Task Force on Occupational Skin Diseases) highlighted the outcomes of the 4th Multi-Stakeholder Summit on Occupational Skin Cancer, made possible by the EADO.

👥 This important summit brought together representatives from the Ministry of Health of Greece, the International Labour Organization (ILO), and the World Health Organization (WHO).

📌 The main objective: to advance recognition of skin cancer as an occupational disease, especially for outdoor workers frequently exposed to the sun. Strengthening prevention and policy efforts can significantly improve worker health worldwide.

📍The discussion continues at EADO 2026 in Prague [LINK IN BIO]

22/09/2025

🌍 We are proud to announce that the European Association of Dermato-Oncology (EADO) is now an official Member of the International League of Dermatological Societies (ILDS)!

A membership in the International League of Dermatological Societies can significantly enhance the European Association of Dermato-Oncology’s global network, foster collaboration with leading dermatology experts, and strengthen its influence in advancing the field of dermato-oncology worldwide.

This marks an exciting step forward in our mission to connect, educate, and support specialists dedicated to skin cancer and complex skin diseases—on a truly global scale.

🤝 We look forward to contributing actively to the ILDS community and shaping the future of dermatology together.

19/09/2025

🧬 Mitochondrial mutations and melanoma: a new layer of response prediction?
At , Prof. Dr. Payam Gammage, mitochondrial biologist and group leader at the CRUK Scotland Institute (Glasgow), presented emerging data on the role of mitochondrial DNA mutations in shaping tumor metabolism, immune activity, and—critically—response to immunotherapy.

📊 His lab has shown that:
– ~50% of melanomas harbor mitochondrial mutations
– These mutations significantly impact the tumor microenvironment
– Patients whose tumors carry mitochondrial DNA mutations may be 2.5× more likely to respond to checkpoint inhibitors

Despite their frequency, mitochondrial mutations remain underexplored in cancer biology—and Prof. Gammage calls for increased attention within the melanoma research community.

🧪 More data to come—see you in Prague for the 22nd EADO Congress 2026.

04/09/2025

At , Dr. Piotr Wojcieszek, radiation oncologist at the National Research Institute of Oncology in Gliwice (Poland), highlighted the role of interventional radiotherapy (brachytherapy) in the treatment of skin cancers.
📍Key points:
– Brachytherapy is used for a wide range of skin cancers, including non-melanoma, and in selected cases, melanoma, sarcoma, or cutaneous lymphomas
– Techniques include surface and interstitial approaches
– Local control can be excellent when delivered by experienced teams
🩺 His core message: radiation oncologists and brachytherapy specialists should be active contributors in multidisciplinary tumor boards, especially when exploring non-surgical strategies.
📆 See you at the 22nd EADO Congress 2026 in Prague—and don’t forget to call your brachytherapy guys.

Adresse

Max-Högger-Strasse 6
Zürich
8048

Webseite

http://www.eado.org/

Benachrichtigungen

Lassen Sie sich von uns eine E-Mail senden und seien Sie der erste der Neuigkeiten und Aktionen von EADO - European Association of Dermato-Oncology erfährt. Ihre E-Mail-Adresse wird nicht für andere Zwecke verwendet und Sie können sich jederzeit abmelden.